MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,120 | -18.9% | 10,612 | +0.8% | 0.00% | -50.0% |
| Q2 2023 | $130,813 | -39.9% | 10,524 | -32.2% | 0.00% | -33.3% |
| Q1 2023 | $217,617 | +5.1% | 15,533 | +7.4% | 0.00% | 0.0% |
| Q4 2022 | $206,966 | -37.8% | 14,463 | +11.0% | 0.00% | -50.0% |
| Q3 2022 | $333,000 | -8.8% | 13,028 | +1.5% | 0.01% | -14.3% |
| Q2 2022 | $365,000 | -15.1% | 12,838 | +5.3% | 0.01% | 0.0% |
| Q1 2022 | $430,000 | -19.5% | 12,197 | -4.2% | 0.01% | -12.5% |
| Q4 2021 | $534,000 | -5.7% | 12,737 | +10.5% | 0.01% | -27.3% |
| Q3 2021 | $566,000 | +57.7% | 11,530 | +33.9% | 0.01% | +57.1% |
| Q2 2021 | $359,000 | – | 8,608 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |